CeQur Simplicity

CeQur Simplicity

Signal active

Organization

Contact Information

Overview

CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin delivery devices that allow a person to administer insulin by clicking the buttons. They work with physicians and centers to bring technology to patients.

About

Industries

Health Care, Medical, Medical Device

Founded

2008

Employees

51-100

Headquarters locations

Horw, Luzern, Switzerland, Europe

Social

Profile Resume

CeQur Simplicity headquartered in Switzerland, Europe, operates in the Health Care, Medical, Medical Device sector. The company focuses on Health Care and has secured $13.0B in funding across 48 round(s). With a team of 51-100 employees, CeQur Simplicity is actively contributing to advancements in Health Care. Their latest funding round, Series A - CeQur Simplicity, raised $29.6M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Douglas Gunthardt

Douglas Gunthardt

CFO and EVP

imagePlace Bradley Paddock

Bradley Paddock

President & CEO

Funding Rounds

Funding rounds

4

Investors

4

Lead Investors

0

Total Funding Amount

$271.6M

Details

4

CeQur Simplicity has raised a total of $271.6M in funding over 4 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Late Stage Venture115.0M
2015Late Stage Venture100.0M
2013Early Stage Venture27.0M
2010Early Stage Venture29.6M

Investors

CeQur Simplicity is funded by 25 investors.

Investor NameLead InvestorFunding RoundPartners
BMC Ventures-FUNDING ROUND - BMC Ventures29.6M
Schroders-FUNDING ROUND - Schroders29.6M
CeQur Simplicity-FUNDING ROUND - CeQur Simplicity29.6M
VI Partners-FUNDING ROUND - VI Partners29.6M

Recent Activity

News

Jun 30, 2024

MassDevice - CeQur wins FDA nod for mealtime insulin delivery device

News

Jun 30, 2024

PRWeb - CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to Further Simplify Diabetes Management

News

Jun 18, 2024

PRWeb - CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to ...

News

Aug 25, 2023

Google Patent - Add-on device for medicament dose tracking

News

Apr 15, 2021

Google Patent - Devices and methods for providing a bolus dose in a microfluidic circuit of a …

Funding Round

Apr 13, 2021

CeQur Simplicity raised $115000000 on 2021-04-13 in Series C